Results 61 to 70 of about 11,723 (189)

Aortic dissection type A, common carotid artery occlusion, and stroke after dapsone for 20 years

open access: yesJournal of Family Medicine and Primary Care
Long-term use of dapsone, a sulfone with anti-inflammatory and immunosuppressive properties, has not been previously reported in association with aortic dissection type A.
Josef Finsterer, Sounira Mehri
doaj   +1 more source

Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption – A prospective monocenter pilot study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the Western world. While remission is achieved in the majority of BP patients by long‐term use of corticosteroids with or without immunomodulants/immunosuppressants, national and international guidelines recommend adjuvant immunoadsorption (IA)
Maike M. Holtsche   +7 more
wiley   +1 more source

Wells syndrome: clinical findings and management in a large cohort of 48 patients

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives: Wells syndrome (WS) is a rare inflammatory skin disorder typically characterized by erythematous, edematous, and pruritic plaques. Despite its distinct histopathological features, WS remains an underdiagnosed disease due to its variable clinical presentations and overlap with other dermatological conditions.
Marco Adriano Chessa   +8 more
wiley   +1 more source

Dapsone poisoning [PDF]

open access: yesBlood, 2019
Lyndsay, McLeod-Kennedy, Mike, Leach
openaire   +2 more sources

A Dermal Plaque on the Arm

open access: yes
JEADV Clinical Practice, EarlyView.
Claudine Howard‐James   +3 more
wiley   +1 more source

Erosive pustular dermatosis of the lower legs (EPDL): A rarely diagnosed neutrophilic dermatosis of the elderly

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Erosive pustular dermatosis of the lower legs (EPDL) is a rarely diagnosed, chronic inflammatory skin disease that occurs predominantly in elderly people. Predisposing factors include skin atrophy, chronic venous insufficiency, and trauma. Although the pathogenesis of EPDL has not yet been conclusively clarified, there are ongoing discussions ...
Joachim Dissemond   +3 more
wiley   +1 more source

Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study

open access: yesClinical Pharmacology: Advances and Applications, 2017
Sanjeev Guragain,1 Namrata Upadhayay,2 Bishwa Mohan Bhattarai3 1Department of Pharmacology, Gandaki Medical College Teaching Hospital and Research Centre, Lekhnath, 2Department of Physiology, Gandaki Medical College Teaching Hospital and Research ...
Guragain S, Upadhayay N, Bhattarai BM
doaj  

Dapsone-induced pure red cell aplasia and cholestatic jaundice: A new experience for diagnosis and management

open access: yesJournal of Research in Pharmacy Practice, 2016
Dapsone (4,4′- diaminodiphenylsulfone) is the parent compound of the sulfones, and it has potent antiparasitic, anti-inflammatory, and immunomodulatory effects.
Kamal Kumar Sawlani   +5 more
doaj   +1 more source

A Case of Blastomycosis Like Pyoderma Responsive to Intralesional Triamcinolone Acetonide Injections

open access: yes
Australasian Journal of Dermatology, EarlyView.
Dasmesh Sron   +3 more
wiley   +1 more source

Mucous Membrane Pemphigoid After Anti‐PD‐1 Therapy: Risk‐Stratified Management and Treatment Outcomes

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Mucous membrane pemphigoid (MMP) following anti‐programmed cell death‐1 (PD‐1) therapy is rare but increasingly reported. Management of high‐ and low‐risk MMP in this setting and the potential oncologic trade‐offs remain poorly defined. We performed a narrative synthesis of all published cases of anti‐PD‐1‐associated MMP, following MEDLINE ...
Serena Dienes   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy